Blog
RSS FeedPosted by Michael Wonder on 26 Jun 2018
New uses for old drugs
26 June 2018 - Low cost generics are an untapped source of therapeutic innovation. ...
Posted by Michael Wonder on 07 Jun 2018
Pfizer wins appeal against £84m UK fine over epilepsy drug price
7 June 2018 - Tribunal finds competition watchdog was wrong in its market dominance conclusions. ...
Posted by Michael Wonder on 28 May 2018
Boots faces probe over NHS drug prices
27 May 2018 - High street pharmacy charged £3,220 for pain-relieving mouthwash that can cost £93. ...
Posted by Michael Wonder on 16 May 2018
Trump threatens to use US trade talks to force NHS to pay more for drugs
15 May 2018 - Donald Trump is ready to use trade talks to force the National Health Service to pay ...
Posted by Michael Wonder on 23 Apr 2018
Company urged to lower cost of life-changing drug for cystic fibrosis
21 April 2018 - Health ministers have urged a pharmaceutical company to drop the price of a life-changing cystic fibrosis ...
Posted by Michael Wonder on 09 Apr 2018
Why do new medicines cost so much, and what can we do about it?
9 April 2018 - The cost of new drugs is putting increasing pressure on people in both rich and poor countries. ...
Posted by Michael Wonder on 03 Mar 2018
Removing the blindfold on medicines pricing
26 February 2018 - Increased transparency would enable more evidence based policy making. ...
Posted by Michael Wonder on 03 Mar 2018
‘Free’ pricing in the UK: the influence of NICE and NHS England
1 March 2018 - Price is a key factor for cost effectiveness. ...
Posted by Michael Wonder on 26 Feb 2018
NHS could claw back £502m if Lyrica ruling upheld, study finds
26 February 2018 - The NHS could reclaim up to £502 million in excess prescribing costs relating to Pfizer’s pregabalin ...
Posted by Michael Wonder on 20 Dec 2017
'Drugs are too expensive for the NHS – and people are paying with their lives’
20 December 2017 - Don’t blame the NHS for denying vital medication, say members of a new activist group, Just Treatment. ...
Posted by Michael Wonder on 21 Nov 2017
Is the NHS being taken for a ride on drug prices? We need to know
21 November 2017 - The competition watchdog is investigating, but we need a wider inquiry into pharmaceutical firms’ practices. ...
Posted by Michael Wonder on 20 Nov 2017
Bureaucracy and duplication: the reality of the PPRS
20 November 2017 - In the fourth in her series of five articles looking at the objectives of the PPRS, ...
Posted by Michael Wonder on 12 Nov 2017
NHS England, Roche come to agreement on Perjeta
10 November 2017 - NHS England and Roche have agreed a confidential commercial agreement on the price of Perjeta for ...
Posted by Michael Wonder on 05 Oct 2017
ABPI update on application for judicial review
4 October 2017 - The ABPI have issued a statement regarding its application for judicial review versus NICE. ...
Posted by Michael Wonder on 30 Sep 2017
Improved access? The reality of the PPRS
29 September 2017 - In the third in her series of five articles, Leela Barham considers the extent to which ...